2026³â 01¿ù 09ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Business

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Waters and BioInfra Establish the ASEAN Academy for Bioanalysis to Promote Analytical Skills Development

Companies collaborate to promote development of bioanalytical skills with joint opening of the ASEAN Academy for Bioanalysis in South Korea
´º½ºÀÏÀÚ: 2022-06-21

SEOUL, SOUTH KOREA-- June 21, 2022 -- Waters Corporation (NYSE:WAT) announced a collaboration with BioInfra, a pioneering contract research organization (CRO) company for the pharmaceutical and clinical fields, to jointly establish the ASEAN Academy for Bioanalysis. The academy is dedicated to providing scientists with the hands-on knowledge required to design and perform a variety of bioanalytical methods, which are vital throughout every stage of drug discovery and development.

“There is a growing need for contract research organizations (CROs), pharmaceutical companies and regulators in the region to have access to the bioanalysis training needed to conduct drug equivalence tests for the approval of generic drugs,” said David Curtin, Waters Vice President of Asia Pacific. “Our vision is that the training provided at the ASEAN Academy will help grow generic drug manufacturing in the region, and in turn, help provide lower cost prescription drug options for the people of Southeast Asia.”

Located at the BioInfra headquarters in Seoul, the ASEAN Academy for Bioanalysis will offer hands-on training using the latest analytical instruments and software from Waters. Trainees will focus on the bioanalytical aspect of bioequivalence trials to ensure they are conducted according to the applicable principles of Good Laboratory Practice (GLP).

Bioanalytical methods used today require samples to be well-characterized, fully validated, and documented to yield reliable results that can be satisfactorily interpreted. These skills will help enhance the regional scientific competitiveness and the quality of pharmaceutical research and testing needed to meet the region’s growing demands for access to clinical trials and generic drugs, which are fueled by rising elderly populations facing acute and chronic illnesses.

“We are thrilled to partner with Waters Corporation on the establishment of the ASEAN Academy for Bioanalysis," said Sang Deuk Lee, CEO of BioInfra. “By providing the scientific community of Southeast Asia with a much-needed resource for bioanalytical training, we are further supporting BioInfra’s mission to create a healthy future for all people, regardless of their age or economic status.”

The ASEAN Academy for Bioanalysis books group training by advance appointment only. Please contact JC Ahn at BioInfra for more information on training details, dates, and pricing.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Andersen Consulting Adds Collaborating Firm Codezilla
Netbank Selects Thredd to Power Next-Generation Cards-as-a-Service Offering Across the Philippines
SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows
ExaGrid Wins 3 New Industry Awards at the MSP Channel Awards
Korea Strengthens Global Standing as Nation Brand Ranks 4th and Competitiveness 17th
SP Electricity North West Moves from Outages to Outstanding Performance with Rimini Street
Loomis Sayles Proudly Celebrates 100 Years of Client Commitment and Investment Excellence

 

Gamma Technologies Strengthens Commitment to Japanese Market with New ...
SoluPet Partners with CHC Healthcare to Drive Canine Cognitive Health ...
PUMA Relaunches Company Magazine CATch UP to Showcase the Best of the ...
Boomi Named a 2025 Geo and Global AWS Partner Award Finalist
NTT DATA appoints CEO of newly established AI Company NTT DATA AIVista...
Andersen Consulting Expands Digital Transformation Capabilities
Brands Poised for Growth: NIQ Identifies the Strategies Behind 2025¡¯s...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..